Seres Therapeutics, Inc. (MCRB) › Total LiabilitiesSeres Therapeutics, Inc. (MCRB) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $7.99M2015: $11.51M2016: $140.01M2017: $128.82M2018: $168.52M2019: $180.76M2020: $168.19M2021: $223.35M2022: $338.00M2023: $403.46M2024: $126.03M2025: $93.97M$93.97M2014Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$93.97M-25.4%2024$126.03M-68.8%2023$403.46M+19.4%2022$338.00M+51.3%2021$223.35M+32.8%2020$168.19M-7.0%2019$180.76M+7.3%2018$168.52M+30.8%2017$128.82M-8.0%2016$140.01M+1116.9%2015$11.51M+44.0%2014$7.99M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share